» Articles » PMID: 31113409

Aminoguanidine Affects Systemic and Lung Inflammation Induced by Lipopolysaccharide in Rats

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2019 May 23
PMID 31113409
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nitric oxide is a mediator of potential importance in numerous physiological and inflammatory processes in the lung. Aminoguanidine (AG) has been shown to have anti-inflammation and radical scavenging properties. This study aimed to investigate the effects of AG, an iNOS inhibitor, on lipopolysaccharide (LPS)-induced systemic and lung inflammation in rats.

Methods: Male Wistar rats were divided into control, LPS (1 mg/kg/day i.p.), and LPS groups treated with AG 50, 100 or 150 mg/kg/day i.p. for five weeks. Total nitrite concentration, total and differential white blood cells (WBC) count, oxidative stress markers, and the levels of IL-4, IFN-γ, TGF-β1, and PGE2 were assessed in the serum or bronchoalveolar lavage fluid (BALF).

Results: Administration of LPS decreased IL-4 level (p < 0.01) in BALF, total thiol content, superoxide dismutase (SOD) and catalase (CAT) activities (p < 0.001) in BALF and serum, and increased total nitrite, malondialdehyde (MDA), IFN-γ, TGF-β1 and PGE2 (p < 0.001) concentrations in BALF. Pre-treatment with AG increased BALF level of IL-4 and total thiol as well as SOD and CAT activities (p < 0.05 to p < 0.001), but decreased BALF levels of total nitrite, MDA, IFN-γ, TGF-β1, and PGE2 (p < 0.01 to p < 0.001). AG treatment decreased total WBC count, lymphocytes and macrophages in BALF (p < 0.01 to p < 0.001) and improved lung pathological changes including interstitial inflammation and lymphoid infiltration (p < 0.05 to p < 0.001).

Conclusions: AG treatment reduced oxidant markers, inflammatory cytokines and lung pathological changes but increased antioxidants and anti-inflammatory cytokines. Therefore, AG may play a significant protective role against inflammation and oxidative stress that cause lung injury.

Citing Articles

Protective effects of myrtenol against paraquat-induced toxicity in rats.

Amin F, Basirat H, Parvaz N, Khademalhosseini M, Hakimizadeh E, Fatemi I BMC Pulm Med. 2025; 25(1):17.

PMID: 39806385 PMC: 11730473. DOI: 10.1186/s12890-025-03484-5.


The effects of camel milk in systemic inflammation and oxidative stress of cigarette smoke-induced chronic obstructive pulmonary disease model in rat.

Behrouz S, Mohammadi M, Sarir H, Boskabady M Front Vet Sci. 2024; 11:1464432.

PMID: 39735585 PMC: 11673985. DOI: 10.3389/fvets.2024.1464432.


Camel milk inhibits pulmonary oxidative stress and inflammation in a rat model of COPD induced by cigarette smoke exposure.

Behrouz S, Mohammadi M, Sarir H, Mohammadian Roshan N, Boskabady M Heliyon. 2024; 10(20):e39416.

PMID: 39497967 PMC: 11532301. DOI: 10.1016/j.heliyon.2024.e39416.


Evaluation of the protective effect of Curcuma longa and PPARγ agonist, pioglitazone on paraquat-induced lung injury in rats.

Eshaghi Ghalibaf M, Taghavi Zadeh Yazdi M, Mansourian M, Mohammadian Roshan N, Boskabady M Immun Inflamm Dis. 2024; 12(8):e70001.

PMID: 39172009 PMC: 11340013. DOI: 10.1002/iid3.70001.


Therapeutic potential of HUC-MSC-exos primed with IFN-γ against LPS-induced acute lung injury.

Wang C, Jiang C, Yang Y, Xi C, Yin Y, Wu H Iran J Basic Med Sci. 2024; 27(3):375-382.

PMID: 38333754 PMC: 10849211. DOI: 10.22038/IJBMS.2023.74372.16156.


References
1.
Hu Y, Wang B, Yang J, Liu T, Sun J, Wang X . Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents. J Enzyme Inhib Med Chem. 2018; 34(1):15-30. PMC: 6211316. DOI: 10.1080/14756366.2018.1518958. View

2.
Weigand M, Horner C, Bardenheuer H, Bouchon A . The systemic inflammatory response syndrome. Best Pract Res Clin Anaesthesiol. 2004; 18(3):455-75. DOI: 10.1016/j.bpa.2003.12.005. View

3.
Hua T, Moochhala S . Influence of L-arginine, aminoguanidine, and NG-nitro-L-arginine methyl ester (L-name) on the survival rate in a rat model of hemorrhagic shock. Shock. 1999; 11(1):51-7. DOI: 10.1097/00024382-199901000-00008. View

4.
Barsig J, Kusters S, Vogt K, Volk H, Tiegs G, Wendel A . Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha. Eur J Immunol. 1995; 25(10):2888-93. DOI: 10.1002/eji.1830251027. View

5.
Ye J, Guan M, Lu Y, Zhang D, Li C, Zhou C . Arbutin attenuates LPS-induced lung injury via Sirt1/ Nrf2/ NF-κBp65 pathway. Pulm Pharmacol Ther. 2018; 54:53-59. DOI: 10.1016/j.pupt.2018.12.001. View